NCT Number: NCT00897624
Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma
RATIONALE: Studying samples of bone marrow and blood from patients with cancer may help doctors find out the extent of disease.
PURPOSE: This research study is collecting bone marrow and blood samples from patients with metastatic choroid melanoma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
Primary
- Develop and validate a method of detecting tumor cells in the bone marrow and blood in patients with metastatic choroid melanoma.
OUTLINE: While patients are under general anesthesia for standard treatment of their disease, samples of bone marrow from the iliac crest and blood are collected. Samples are analyzed for the expression of tyrosinase and Melan-a via RT-PCR.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Choroid melanoma
- Metastatic disease
- Planning to undergo general anesthesia
PATIENT CHARACTERISTICS:
- Not pregnant or nursing
- No contraindications to the collection of a bone marrow sample
- No patient deprived of liberty or under trusteeship (including guardianship)
- No social or psychological situations that preclude the ability to give consent
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
reverse transcriptase-polymerase chain reaction
Geneticlaboratory biomarker analysis
OtherPrimary outcomes
-
Detection of micro-metastatic cells in 20 x 10^6 nucleated cells
Sponsors and collaborators
Lead sponsor
Institut Curie
Other
Registry information
Official study title
Evaluation of the Detection of Tumor Cells in Bone Marrow and Blood in Patients With Choroid Melanoma
Important dates
- Study start
- 2007
- Primary completion
- 2011
- First posted
- May 12, 2009
- Registry last updated
- May 13, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
NCT00445965
Adnexal Diseases, Astrocytoma
New York, United States
View Trial DetailsMonoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
NCT00084656
Eye Diseases, Eye Neoplasms
Tampa, Florida, United States
View Trial DetailsHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
NCT00324727
Eye Diseases, Eye Neoplasms
Santa Monica, California, United States
View Trial DetailsAZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
NCT00243061
Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size
Toronto, Ontario, Canada
View Trial Details